Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$33.11 - $55.01 $89,231 - $148,251
-2,695 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$56.61 - $80.46 $218,288 - $310,253
-3,856 Reduced 58.86%
2,695 $169,000
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $564,892 - $820,119
6,551 New
6,551 $608,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $83,333 - $109,713
-1,498 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $56,579 - $71,529
1,498
1,498 $69,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $561M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.